[1] Squires JE, McKiernan P, Squires RH. Acute liver failure: An update. Clin Liver Dis,2018,22: 773-805.
[2] Weiss E, Paugam-Burtz C, Jaber S. Shock etiologies and fluid management in liver failure. Semin Respir Crit Care Med,2018,39: 538-545.
[3] Garcia D, Shaw RJ. AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell,2017, 66: 789-800.
[4] Tian W, Zhao J, Choo BK, et al. Camellia japonica diminishes acetaminophen-induced acute liver failure by attenuating oxidative stress in mice. Environ Sci Pollut Res Int,2021, 28: 57192-57206.
[5] Wang F, Gong S, Wang T, et al. Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice. Theranostics,2020, 10: 2714-2726.
[6] Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol,2018, 19: 121-135.
[7] Al-Bari MAA, Xu P. Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways. Ann N Y Acad Sci,2020, 1467: 3-20.
[8] Ke R, Xu Q, Li C, et al. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell Biol Int,2018, 42: 384-392.
[9] Zhao H, Li T, Wang K, et al. AMPK-mediated activation of MCU stimulates mitochondrial Ca2+ entry to promote mitotic progression. Nat Cell Biol,2019, 21: 476-486.
[10] Joshi T, Singh AK, Haratipour P, et al. Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications. J Cell Physiol,2019, 234: 17212-17231.
[11] Bunchorntavakul C, Reddy KR. Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and acute liver failure. Clin Liver Dis,2018, 22: 325-346.
[12] Zhao Z, Wei Q, Hua W, et al. Hepatoprotective effects of berberine on acetaminophen-induced hepatotoxicity in mice. Biomed Pharmacother,2018, 103: 1319-1326.
[13] Shi C, Xue W, Han B, et al. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. Eur J Pharmacol,2019, 850: 15-22.
[14] Lv H, Hong L, Tian Y, et al. Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3β-Nrf2 signaling pathway. Cell Commun Signal,2019, 17: 2.
[15] Wang Q, Liu W, Liu G, et al. AMPK-mTOR-ULK1-mediated autophagy protects carbon tetrachloride-induced acute hepatic failure by inhibiting p21 in rats. J Toxicol Pathol,2021, 34: 73-82.
[16] Xu S, Ma Y, Chen Y, et al. Role of forkhead box O3a transcription factor in autoimmune diseases. Int Immunopharmacol,2021, 92: 107338.
[17] Liu YM, Lv J, Zeng QL, et al. AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy. Exp Cell Res,2017, 358: 335-342.
[18] Li J, Chen B, Zhong L, et al. AMP-activated protein kinase agonist N6-(3-hydroxyphenyl)adenosine protects against fulminant hepatitis by suppressing inflammation and apoptosis. Cell Death Dis,2018, 9: 37.
[19] Dagon Y, Avraham Y, Ilan Y, et al. Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J,2007, 21: 2431-2441.
[20] Cornut M, Bourdonnay E, Henry T. Transcriptional regulation of inflammasomes. Int J Mol Sci,2020, 21: 8087.
[21] Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci,2019, 20:3328.
[22] Moretti J, Blander JM. Increasing complexity of NLRP3 inflammasome regulation. J Leukoc Biol,2021, 109: 561-571.
[23] Al Mamun A, Akter A, Hossain S, et al. Role of NLRP3 inflammasome in liver disease. J Dig Dis,2020, 21: 430-436.
[24] Afonina IS, Zhong Z, Karin M, et al. Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol,2017, 18:861-869.
[25] Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol,2015, 12: 387-400.
[26] Liu Y, Lou G, Li A, et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine,2018, 36: 140-150.
[27] Kim SJ, Lee SM. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Free Radic Biol Med,2013, 65: 997-1004.
[28] Zhao Q, Wu CS, Fang Y, et al. Glucocorticoid regulates NLRP3 in acute-on-chronic hepatitis B liver failure. Int J Med Sci,2019, 16: 461-469.
[29] Kirchner J, Brüne B, Namgaladze D. AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages. Sci Rep,2018, 8: 7801.
[30] Wang Q, Wei S, Zhou S, et al. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction. Immunol Cell Biol,2020, 98: 54-66.
[31] Lv H, Liu Y, Zhang B, et al. The improvement effect of gastrodin on LPS/GalN-induced fulminant hepatitis via inhibiting inflammation and apoptosis and restoring autophagy. Int Immunopharmacol,2020, 85: 106627.
[32] Lv H, An B, Yu Q, et al. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis. Int J Biol Macromol,2020, 155: 1092-1104. |
